Stoner Elizabeth 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Aug 28, 2018
Insider Transaction Report
Form 4
Stoner Elizabeth
Director
Transactions
- Sale
Common Stock
2018-08-27$27.33/sh−4,152$113,474→ 29,639 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-08-27−6,000→ 5,750 totalExercise: $13.16From: 2015-06-12Exp: 2024-06-12→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2018-08-27$13.16/sh+6,000$78,960→ 33,791 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $27.20 to $27.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.